Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Access to new technologies paramount, says AdvaMed

This article was originally published in Clinica

Executive Summary

The US Health Care Financing Administration (HCFA) notice of intent to publish Medicare coverage criteria is "fundamentally flawed and would ultimately restrict patient access to lifesaving and life enhancing medical tests and treatments." That was the view of AdvaMed president Pamela Bailey in formal comments posted on June 30. The association goes on nevertheless to salute HCFA for embarking on the initiative, while voicing strong reservations about the notice, which, it says, HCFA "should withdraw".

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT076684

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel